Literature DB >> 23092778

Male lower urinary tract symptoms associated with overactive bladder.

Marcus J Drake1.   

Abstract

Lower urinary tract symptoms (LUTS) associated with overactive bladder (OAB) are more likely to respond to antimuscarinic therapy than to alpha blockade. As such, initial treatment of men with storage symptoms should incorporate an antimuscarinic agent. For men who are truly refractory to current pharmacotherapies, there is emerging evidence to support the use of botulinum toxin A.

Entities:  

Year:  2012        PMID: 23092778      PMCID: PMC3481948          DOI: 10.5489/cuaj.12202

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  5 in total

Review 1.  Mirabegron, a β₃-adrenoceptor agonist for the potential treatment of urinary frequency, urinary incontinence or urgency associated with overactive bladder.

Authors:  Pradeep Tyagi; Vikas Tyagi
Journal:  IDrugs       Date:  2010-10

Review 2.  Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.

Authors:  M J Drake; C J Fowler; D Griffiths; E Mayer; J F R Paton; L Birder
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

3.  Combination treatment with propiverine hydrochloride plus doxazosin controlled release gastrointestinal therapeutic system formulation for overactive bladder and coexisting benign prostatic obstruction: a prospective, randomized, controlled multicenter study.

Authors:  Kyu-Sung Lee; Myung-Soo Choo; Duk-Yoon Kim; Joon Chul Kim; Hyung-Jee Kim; Kweon Sik Min; Jong Bouk Lee; Hee Jong Jeong; Tack Lee; Won Hee Park
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

Review 4.  Neural control of the lower urinary tract: peripheral and spinal mechanisms.

Authors:  L Birder; W de Groat; I Mills; J Morrison; K Thor; M Drake
Journal:  Neurourol Urodyn       Date:  2010       Impact factor: 2.696

5.  Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.

Authors:  Paul Abrams; Steven Kaplan; Hendrik J De Koning Gans; Richard Millard
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

  5 in total
  2 in total

Review 1.  Refractory overactive bladder: a common problem?

Authors:  Ulrich Schwantes; Joachim Grosse; Andreas Wiedemann
Journal:  Int Urogynecol J       Date:  2015-03-20       Impact factor: 2.894

2.  Incidence of urinary retention during treatment with single tablet combinations of solifenacin+tamsulosin OCAS™ for up to 1 year in adult men with both storage and voiding LUTS: A subanalysis of the NEPTUNE/NEPTUNE II randomized controlled studies.

Authors:  Marcus J Drake; Matthias Oelke; Robert Snijder; Monique Klaver; Klaudia Traudtner; Karin van Charldorp; Dominique Bongaerts; Philip Van Kerrebroeck
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.